The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

Vall d'Hebron has coordinated this initiative that has carried out numerous training and community awareness activities aimed at empowering young people in sexual and reproductive health issues.

A study by the Infectious Diseases group at VHIR has found that some people with HIV can uniquely control the virus thanks to a special type of cell in their immune system.

The awarded projects will study the immune response to HIV and the VIGex tool as a biomarker for immunotherapy response.

The study aims to investigate how excess body fat alters the number and function of T lymphocytes, leading to a greater predisposition to infectious diseases.

This project will make societies aware of their rights related to sexual and reproductive health and empower young people to make informed and appropriate choices.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

The new protocol has the same efficacy as the standard one, but only a quarter of the duration, reducing dropout rates and side effects.

The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease

The study shows that blocking the KLRG1 receptor helps to recover the activity of the natural killer cells of the immune system and reactivate the virus reservoir to fight infection.

This new method improves and streamlines drug development processes

Members of the Infectious Diseases research group and the VHIR Management participated in the sessions and visited the areas where the CRESCER and FUTURO projects are developed.

The research, which is part of the CRESCER project in which Vall d'Hebron participates, has 1423 pregnant women among whom two different interventions will be tested.

The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

A través dels grups de recerca de Malalties Infeccioses i de Microbiologia, participem en assaigs clínics per trobar nous esquemes terapèutics per a les persones amb tuberculosi.

The team works in the African country with research projects aimed at the control of infectious diseases, chronic malnutrition and sexual and reproductive health.

Hakima Ouaarab Essadek, del Centre de Salut Internacional i Malalties Transmissibles Drassanes-Vall d'Hebron, assessorarà en el Departament de Salut en l’abordatge de les desigualtats de gènere.

The sessions have brought together experts who have presented the advances and knowledge generated in the area of HIV infection.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

Els ajuts impulsaran estudis en els camps del VIH, les hepatitis virals i la COVID-19.

The research, published in The Lancet, studied patients in Barcelona and Madrid, and shows that direct contact is the main route of transmission for the disease.

HIV infected cells expressing the CD32 molecule are more resistant to the action of the natural killer cells of the immune system, which are key in the fight against viral infections.